NCT01025583

Brief Summary

Hypotonic oral rehydration solutions (ORS) containing zinc and/or prebiotics have been proposed for the treatment of pediatric acute diarrhea but conclusive clinical data about their effect are scanty, especially for children living in developed countries. The investigators aim to evaluate the efficacy of a new hypotonic ORS containing zinc and prebiotics in children with acute diarrhea.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Nov 2007

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2007

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2008

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2008

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

December 2, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 3, 2009

Completed
Last Updated

January 13, 2010

Status Verified

December 1, 2009

Enrollment Period

2 months

First QC Date

December 2, 2009

Last Update Submit

January 12, 2010

Conditions

Keywords

acute gastroenteritisintestinal infectionintestinal fluid secretionintestinal microfloratreatment of childhood acute diarrhea

Outcome Measures

Primary Outcomes (1)

  • The primary outcome of the study is the rate of resolution of diarrhea 72 h after starting oral rehydration therapy.

    From November 2007 to January 2008

Secondary Outcomes (1)

  • Secondary outcome measures are the total amount of ORS intake in the first 24 h, the number of missed work days of the parent, the number of hospital admissions in each group, and the use of other medications.

    From November 2007 to January 2008

Study Arms (2)

group 1 (standard ORS)

ACTIVE COMPARATOR

Children with acute diarrhea receive standard hypotonic ORS.

Dietary Supplement: hypotonic oral rehydration solution

Group 2 (hypotonic super-ORS)

ACTIVE COMPARATOR

Children with acute diarrhea receive hypotonic super-ORS containing zinc and prebiotics.

Dietary Supplement: Hypotonic oral rehydration solution with Zn and prebiotics

Interventions

30-50 ml/kg of ORS in 3-4 h for mild dehydration and with 50-100 ml/kg of ORS in 3-4 h for moderate dehydration, and to administer 10 ml/kg/die of ORS in a graduated glass or bottle for dehydration prevention until cessation of symptoms.

Also known as: REIDRAX
group 1 (standard ORS)

30-50 ml/kg of ORS in 3-4 h for mild dehydration and with 50-100 ml/kg of ORS in 3-4 h for moderate dehydration, and to administer 10 ml/kg/die of ORS in a graduated glass or bottle for dehydration prevention until cessation of symptoms.

Also known as: PREREID
Group 2 (hypotonic super-ORS)

Eligibility Criteria

Age3 Months - 36 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children 3-36 months old seen in the pediatrician offices presenting acute diarrhea lasting less than 48 h are considered eligible for the study

You may not qualify if:

  • Diarrhea lasting more than 48 h
  • Malnutrition as judged by a body weight/height ratio below the 5th percentile
  • Clinical signs of severe dehydration
  • Clinical signs of a coexisting severe acute systemic illness (meningitis, sepsis, pneumonia)
  • Immunodeficiency
  • Underlying severe chronic disease
  • Malnutrition
  • Cystic fibrosis
  • Food allergy or other chronic gastrointestinal diseases
  • Use of pre/probiotics in the previous 3 weeks
  • Use of antibiotics or any antidiarrheal medication in the previous 3 weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pediatric Office

Naples, 80100, Italy

Location

MeSH Terms

Conditions

Diarrhea

Interventions

Prebiotics

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Dietary FiberDietary CarbohydratesCarbohydratesPolysaccharides, BacterialPolysaccharidesFoodDiet, Food, and NutritionPhysiological PhenomenaDietary SupplementsFood and Beverages

Study Officials

  • Roberto Berni Canani, MD, PhD

    Department of Pediatrics, University Federico II of Naples Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 2, 2009

First Posted

December 3, 2009

Study Start

November 1, 2007

Primary Completion

January 1, 2008

Study Completion

March 1, 2008

Last Updated

January 13, 2010

Record last verified: 2009-12

Locations